動的グラシロプラスティは,糞便不便症の治療のために使用されます
C G Baeten1, J Konsten, F Spaans
1Department of Surgery, Maastricht University Hospital, Netherlands.
Lancet (London, England)
|November 9, 1991
まとめ
ダイナミック・グラシロプラスティは,重度の排泄不便症の患者において,排泄不便を回復します. この手術技術は,電気的に刺激されたグラシリス筋肉を使用して,他の治療法が失敗したときに門門の機能と生活の質を改善します.
科学分野:
- 結腸直腸外科手術について
- バイオメディカルエンジニアリング
- 骨盤床リハビリテーション
背景:
- 重篤な排泄不便は,しばしば外科的介入を必要とします.
- 伝統的なグラシロプラスティは,筋肉の疲労のために成功が限られている.
- ダイナミック (電気刺激) グラシロプラスティは,改善された結果の有望さを示しています.
研究 の 目的:
- 完全内不便症の患者におけるダイナミック・グラシロプラスティの有効性を評価する.
- この処置が門門の圧力と制に与える影響を評価する.
- ダイナミックグラシロプラスティが耐火性の患者の生活の質を改善するかどうかを判断する.
主な方法:
- 完全のアナル不便症の患者10人は,グラシリス筋の転移を施しました.
- 筋肉内導線と埋め込み可能な電気刺激器は,手術後6週間で埋め込まれました.
- 門スフィンクターの圧力,リン酸エネマの保持時間,およびデファエコグラフィーが評価されました.
主要な成果:
- 10人の患者のうち8人は控えめ状態を達成しました.
- 刺激により,門門の平均圧力は (35~62mmHg) 大きく増加した.
- 平均のリン酸エネマ保持時間は22秒から281秒に増加した.
結論:
- ダイナミック・グラシロプラスティは,重度の排泄不便の場合は,抑留を回復するための効果的な外科的選択肢です.
- この処置は,門門の機能と患者の生活の質を大幅に改善します.
- このテクニックは,他の治療法に反応しない患者に有効な解決策を提供します.
関連する概念動画
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:


